| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| VDR |
Deoxycholic Acid |
NA |
NA|150000 |
NA |
150000|NA |
NA |
NA |
PubChem|TTD |
| VDR |
Ursodiol |
NA |
NA|150000 |
NA |
150000|NA |
NA |
NA |
PubChem|TTD |
| VDR |
Taurolithocholic Acid |
NA |
NA |
NA |
150000 |
NA |
NA |
PubChem |
| VDR |
Hyodeoxycholic Acid |
NA |
150000|NA |
NA |
NA|150000 |
NA |
NA |
PubChem|TTD |
| VDR |
Achromycin |
NA |
NA |
NA |
NA |
112202 |
NA |
PubChem |
| VDR |
Lysergide |
NA |
NA |
NA |
NA |
179160 |
NA |
PubChem |
| VDR |
Prednisone |
NA |
NA |
NA |
NA |
112202 |
NA |
PubChem |
| VDR |
2-Phenylphenol |
NA |
NA |
NA |
NA |
251189|398107 |
NA |
PubChem |
| VDR |
N-[1-(2-methyl-1H-indol-3-yl)ethyl]aniline |
NA |
104800 |
NA |
NA |
NA |
NA |
BindingDB |
| VDR |
(3R,6S,9S,15R)-15-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-12,12-dimethyl-6,9-bis(2-methylpropyl)-5,8,11,14-tetraoxo-1,17-dioxa-4,7,10,13-tetrazacyclohenicosane-3-carboxylic acid |
NA |
600000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| VDR |
(3S,6S,9S,15S)-15-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-12,12-dimethyl-6,9-bis(2-methylpropyl)-5,8,11,14-tetraoxo-1,18-dioxa-4,7,10,13-tetrazacyclodocosane-3-carboxylic acid |
NA |
520000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| VDR |
(4S,7S,10S,16S)-16-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-13,13-dimethyl-7,10-bis(2-methylpropyl)-6,9,12,15-tetraoxo-1,19-dioxa-5,8,11,14-tetrazacyclotricosane-4-carboxylic acid |
NA |
220000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| VDR |
(3S,6S,9S,15S)-15-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-12,12-dimethyl-6,9-bis(2-methylpropyl)-5,8,11,14-tetraoxo-1,17-dioxa-4,7,10,13-tetrazacyclohenicosane-3-carboxylic acid |
NA |
610000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| VDR |
(3R,6S,9S,15S)-15-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-12,12-dimethyl-6,9-bis(2-methylpropyl)-5,8,11,14-tetraoxo-1,17-dioxa-4,7,10,13-tetrazacyclohenicosane-3-carboxylic acid |
NA |
430000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| VDR |
(3S,6S,9S,15R)-15-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-12,12-dimethyl-6,9-bis(2-methylpropyl)-5,8,11,14-tetraoxo-1,17-dioxa-4,7,10,13-tetrazacyclohenicosane-3-carboxylic acid |
NA |
610000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| VDR |
N-[(2-chlorophenyl)-(2,6-dimethyl-1H-indol-3-yl)methyl]-2-methoxypyridin-3-amine |
NA |
101400 |
NA |
NA |
NA |
NA |
BindingDB |
| VEGFA |
[(2S,3S,4S,5R,6R)-2-methoxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)oxan-4-yl] sulfate |
NA |
NA |
198000 |
NA |
NA |
NA |
BindingDB |
| VEGFA |
[(2R,3R,4S,5S,6S)-2-[[[2-[acetyl(cyclododecyl)amino]acetyl]amino]methyl]-6-methoxy-3,5-disulfonatooxyoxan-4-yl] sulfate |
NA |
NA |
1200000 |
NA |
NA |
NA |
BindingDB |
| VEGFA |
[(2R,3R,4S,5S,6S)-2-[[[2-[acetyl(2-phenylethyl)amino]acetyl]amino]methyl]-6-methoxy-3,5-disulfonatooxyoxan-4-yl] sulfate |
NA |
NA |
109000 |
NA |
NA |
NA |
BindingDB |
| VEGFA |
[(2R,3R,4S,5S,6S)-2-[[[2-[acetyl(cyclohexyl)amino]acetyl]amino]methyl]-6-methoxy-3,5-disulfonatooxyoxan-4-yl] sulfate |
NA |
NA |
1700000 |
NA |
NA |
NA |
BindingDB |